mofezolac has been researched along with Disease Models, Animal in 3 studies
mofezolac: Cyclooxygenase 1 inhibitor; structure in first source; RN from Toxlit
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Rostevanov, IS | 1 |
| Boyko, M | 1 |
| Ferorelli, S | 1 |
| Scilimati, A | 1 |
| Perrone, MG | 1 |
| Kaplanski, J | 1 |
| Zlotnik, A | 1 |
| Azab, AN | 1 |
| Kitamura, T | 1 |
| Kawamori, T | 1 |
| Uchiya, N | 1 |
| Itoh, M | 1 |
| Noda, T | 1 |
| Matsuura, M | 1 |
| Sugimura, T | 1 |
| Wakabayashi, K | 1 |
| Yoshida, S | 1 |
| Amano, H | 1 |
| Hayashi, I | 1 |
| Kitasato, H | 1 |
| Kamata, M | 1 |
| Inukai, M | 1 |
| Yoshimura, H | 1 |
| Majima, M | 1 |
3 other studies available for mofezolac and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of cyclooxygenase-1 does not reduce mortality in post-ischemic stroke rats.
Topics: Animals; Brain; Cyclooxygenase Inhibitors; Disease Models, Animal; Female; Ischemic Stroke; Isoxazol | 2020 |
Inhibitory effects of mofezolac, a cyclooxygenase-1 selective inhibitor, on intestinal carcinogenesis.
Topics: Animals; Antineoplastic Agents; Azoxymethane; Carcinogenicity Tests; Cyclooxygenase 1; Cyclooxygenas | 2002 |
COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo.
Topics: Animals; Antibodies, Blocking; Aspirin; Benzenesulfonates; Carcinoma, Lewis Lung; Cyclooxygenase Inh | 2003 |